Paricalcitol

Paricalcitol
Product Description

Paricalcitol is a synthetic vitamin D analogue. Paricalcitol has been used to reduce parathyroid hormone levels. It is still in R&D stage, and estimated to be approved by 2020.

Jiangsu Hengrui Medicine Co., Ltd.

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Manufacturer/Innovator
Specifications
  • CAS Registry Number
    131918-61-1
  • Supplied from
    China

Jiangsu Hengrui Medicine Co., Ltd.

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Manufacturer/Innovator

More Products from Jiangsu Hengrui Medicine Co., Ltd. (99)

  • Desflurane for inhalation

    Product Desflurane for inhalation

    Desflurane is a highly fluorinated methyl ethyl ether used for maintenance of general anesthesia.

    Strength: 240ml

    It is approved by NMPA.
    It is approved by US-FDA and EU.

  • Dexmedetomidine HCl Injection

    Product Dexmedetomidine HCl Injection

    Dexmedetomide HCl is an anxiolytic, sedative, andanalgesic medication.

    Strength: 200mcg/2ml (100mcg/ml); Single-dose Vial
    This product has been approved by CFDA and US-FDA.

    Strength: 80mcg/20ml; 200mcg/50ml; 400mcg/100ml
    This product has been app...
  • Atracurium Besylate

    Product Atracurium Besylate

    Atracurium besylate is a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxatio...
  • Butorphanol Tartrate

    Product Butorphanol Tartrate

    Butorphanol Tartate is a morphinan-type synthetic opioid analgesic.

    It is approved by NMPA.
  • Salmeterol xinafoate + Fluticasone propionate

    Product Salmeterol xinafoate + Fluticasone propionate

    It is indicated for asthma.It is still in R&D stage.
  • Sugammadex Sodium

    Product Sugammadex Sodium

    Sugammadex is a selective relaxant binding agent indicated for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide during surgery in adults.It is still in R&D stage and estimated to be approved by 2020.
  • Ondansetron

    Product Ondansetron

    A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.It is still in R&D stage and estimated to be approved by 2020.
  • Febuxostat

    Product Febuxostat

    Febuxostat is a xanathine oxidase (XO) inhibitor indicated in patients with gout suffering from hyperuricemia and is used in its chronic management.It is still in R&D stage and estimated to be approved by 2020.
  • Capecitabine

    Product Capecitabine

    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of numerous cancers. It is a prodrug that is enzymatically converted to 5-fluorouracil (5-FU) in the body.

    It is approved by NMPA.
  • Caspofungin Acetate

    Product Caspofungin Acetate

    Caspofungin Acetate is a lipopeptide antifungal drug. It is a member of a new class of antifungals termed the echinocandins. It works by inhibiting the enzyme (1→3)-β-D-glucan synthase and thereby disturbing the integrity of the fungal cell wall. Caspofungin was the ...
  • Celecoxib

    Product Celecoxib

    Celecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the pain and inflammation of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain in adults, painful menstruation, and juvenile rheumatoid arthrit...
  • Cisatracurium Besylate

    Product Cisatracurium Besylate

    Cisatracurium Besylate is a bisbenzyltetrahydroisoquinolinium that has effect as a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively inanesthesia to facilitate endotracheal intubation&nbs...

Jiangsu Hengrui Medicine Co., Ltd. resources (1)